AR aberrations and resistance to abiraterone or enzalutamide
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://www.nature.com/articles/nrurol.2016.212.pdf
Reference10 articles.
1. Nakazawa, M., Antonarakis, E. S. & Luo, J. Androgen receptor splice variants in the era of enzalutamide and abiraterone. Horm. Cancer 5, 265–273 (2014).
2. Antonarakis E. S. et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N. Engl. J. Med. 371, 1028–1038 (2014).
3. Romanel, A. et al. Plasma AR and abiraterone-resistant prostate cancer. Sci. Transl Med. 7, 312re310 (2015).
4. Wyatt, A. W. et al. Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer. JAMA Oncol. http://dx.doi.org/10.1001/jamaoncol.2016.0494 (2016).
5. Scher, H. I. et al. Association of AR-V7 on circulating tumor cells as a tTeatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer. JAMA Oncol., http://dx.doi.org/10.1001/jamaoncol.2016.1828 (2016).
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway;Neoplasia;2024-11
2. Cancer on motors: How kinesins drive prostate cancer progression?;Biochemical Pharmacology;2024-06
3. Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer;Journal of Experimental & Clinical Cancer Research;2024-02-27
4. Sinularin stabilizes FOXO3 protein to trigger prostate cancer cell intrinsic apoptosis;Biochemical Pharmacology;2024-02
5. Functional Role of Non-coding RNAs in Prostate Cancer: From Biomarker to Therapeutic Targets;RNA Technologies;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3